NYSE:STE - STERIS Stock Price, Price Target & More

Get Started

$103.69 -0.80 (-0.77 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$104.49

Today's Range$103.17 - $105.39

52-Week Range$76.47 - $105.39

Volume249,400 shs

Average Volume374,307 shs

Market Capitalization$8.88 billion

P/E Ratio24.99

Dividend Yield1.18%

Beta1.12

About STERIS (NYSE:STE)

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:STE

CUSIP85915210

Webwww.steris.com

Phone44-13-3238-7100

Debt

Debt-to-Equity Ratio0.41

Current Ratio2.48

Quick Ratio1.97

Price-To-Earnings

Trailing P/E Ratio24.99

Forward P/E Ratio22.01

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.62 billion

Price / Sales3.36

Cash Flow$5.3421 per share

Price / Cash19.41

Book Value$37.92 per share

Price / Book2.73

Profitability

EPS (Most Recent Fiscal Year)$4.15

Net Income$290.91 million

Net Margins11.10%

Return on Equity11.55%

Return on Assets6.93%

Miscellaneous

Employees12,000

Outstanding Shares84,850,000

STERIS (NYSE:STE) Frequently Asked Questions

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Friday, May 11th. Shareholders of record on Friday, June 8th will be paid a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Thursday, June 7th. View STERIS's Dividend History.

How were STERIS's earnings last quarter?

STERIS (NYSE:STE) released its earnings results on Wednesday, May, 9th. The medical equipment provider reported $1.24 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.02. The medical equipment provider had revenue of $716 million for the quarter, compared to analysts' expectations of $703.37 million. STERIS had a return on equity of 11.55% and a net margin of 11.10%. STERIS's quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.11 EPS. View STERIS's Earnings History.

When is STERIS's next earnings date?

STERIS is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for STERIS.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY19 earnings guidance on Wednesday, May, 9th. The company provided earnings per share guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus estimate of $4.69.

What price target have analysts set for STE?

5 equities research analysts have issued 1-year price targets for STERIS's shares. Their predictions range from $16.00 to $103.00. On average, they expect STERIS's share price to reach $80.25 in the next twelve months. View Analyst Ratings for STERIS.

Who are some of STERIS's key competitors?

Some companies that are related to STERIS include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), Coloplast (CLPBY), Smith & Nephew (SNN), William Demant (WILYY), Inogen (INGN), Mine Safety Appliances (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), Consort Medical (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX) and Lakeland Industries (LAKE).

Who are STERIS's key executives?

STERIS's management team includes the folowing people:

Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)

Has STERIS been receiving favorable news coverage?

Headlines about STE stock have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. STERIS earned a coverage optimism score of 0.16 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 46.82 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Who are STERIS's major shareholders?

STERIS's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.81%), Massachusetts Financial Services Co. MA (2.55%), Westfield Capital Management Co. LP (1.95%), Principal Financial Group Inc. (1.93%), Principal Financial Group Inc. (1.93%) and Fisher Asset Management LLC (1.71%). Company insiders that own STERIS stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for STERIS.

Which institutional investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Champlain Investment Partners LLC, Envestnet Asset Management Inc., Fisher Asset Management LLC, Westfield Capital Management Co. LP, Daiwa Securities Group Inc. and Public Employees Retirement Association of Colorado. Company insiders that have sold STERIS company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for STERIS.

Which institutional investors are buying STERIS stock?

STE stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Robeco Institutional Asset Management B.V., BlackRock Inc., Massachusetts Financial Services Co. MA, Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN and Chicago Equity Partners LLC. View Insider Buying and Selling for STERIS.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $103.69.

How big of a company is STERIS?

STERIS has a market capitalization of $8.88 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. STERIS employs 12,000 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]

MarketBeat Community Rating for STERIS (STE)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		159 (Vote Outperform)
Underperform Votes:		235 (Vote Underperform)
Total Votes:		394

MarketBeat's community ratings are surveys of what our community members think about STERIS and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

STERIS (NYSE:STE) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for STERIS in the last 12 months. Their average twelve-month price target is $80.25, suggesting that the stock has a possible downside of 22.61%. The high price target for STE is $103.00 and the low price target for STE is $16.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.60	2.60	2.60	2.60
Ratings Breakdown:	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$80.25	$80.25	$80.25	$72.00
Price Target Upside:	22.61% downside	4.68% downside	4.68% downside	18.34% downside

STERIS (NYSE:STE) Consensus Price Target History

Price Target History for STERIS (NYSE:STE)

STERIS (NYSE:STE) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/8/2018	KeyCorp	Reiterated Rating	Buy	$103.00	Medium
2/8/2018	Northcoast Research	Set Price Target	Buy	$102.00	Medium
1/3/2018	Raymond James	Reiterated Rating	Outperform ➝ Market Perform	$100.00	High
11/9/2017	TD Securities	Boost Price Target	Buy	C$14.00 ➝ C$16.00	N/A
6/5/2017	Wellington Shields	Downgrade	Gradually Accumulate ➝ Hold		Low
11/30/2016	Goldman Sachs Group	Initiated Coverage	Neutral	$71.00	N/A
11/4/2016	JMP Securities	Reiterated Rating	Buy		N/A

(Data available from 5/26/2016 forward)

STERIS (NYSE:STE) Earnings History and Estimates Chart

Earnings by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Earnings Estimates

2018 EPS Consensus Estimate: $4.05
2019 EPS Consensus Estimate: $4.74

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.80	$0.82	$0.81
Q2 2018	2	$0.92	$0.94	$0.93
Q3 2018	2	$1.06	$1.11	$1.09
Q4 2018	2	$1.22	$1.22	$1.22
Q1 2019	2	$0.96	$0.99	$0.98
Q2 2019	2	$1.07	$1.12	$1.10
Q3 2019	2	$1.24	$1.28	$1.26
Q4 2019	2	$1.39	$1.42	$1.41

STERIS (NYSE STE) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/6/2018		$0.99					N/A
5/9/2018	Q4 2018	$1.22	$1.24	$703.37 million	$716.00 million	View	Listen
2/7/2018	Q3 2018	$1.07	$1.12	$663.17 million	$661.90 million	View	N/A
11/1/2017	Q2 2018	$0.95	$0.94	$629.02 million	$634.20 million	View	N/A
8/8/2017	Q1 2018	$0.80	$0.85	$597.66 million	$608.00 million	View	Listen
5/9/2017	Q4	$1.07	$1.11	$673.47 million	$681.20 million	View	Listen
2/7/2017	Q317	$1.04	$0.98	$680.13 million	$646.80 million	View	Listen
11/2/2016	Q217	$0.90	$0.89	$670.24 million	$646.40 million	View	N/A
8/9/2016	Q117	$0.77	$0.79	$639.04 million	$638.40 million	View	Listen
5/18/2016	Q416	$1.04	$0.90	$701.92 million	$690.30 million	View	Listen
2/9/2016	Q316	$0.94	$0.98	$617.35 million	$618.70 million	View	N/A
10/30/2015	Q216	$0.76	$0.83	$488.66 million	$489.90 million	View	Listen
8/4/2015	Q415	$0.61	$0.62	$439.23 million	$439.90 million	View	Listen
5/7/2015	Q4	$0.89	$0.98	$520.07 million	$501.60 million	View	Listen
2/4/2015	Q315	$0.73	$0.79	$475.22 million	$473.20 million	View	Listen
11/4/2014	Q215	$0.62	$0.68	$452.50 million	$462.70 million	View	Listen
8/5/2014	Q115	$0.54	$0.54	$418.26 million	$412.60 million	View	Listen
5/8/2014	Q4	$0.86	$0.91	$455.92 million	$465.30 million	View	Listen
2/5/2014	Q314	$0.69	$0.59	$406.40 million	$405.60 million	View	Listen
10/30/2013	Q214	$0.54	$0.55	$376.82 million	$383.80 million	View	Listen
8/7/2013	Q1 2014	$0.56	$0.44	$372.69 million	$367.70 million	View	Listen
5/7/2013	Q4 2013	$0.65	$0.70	$405.79 million	$426.20 million	View	Listen
2/6/2013	Q3 2013	$0.56	$0.58	$368.84 million	$380.40 million	View	Listen
10/31/2012	Q213	$0.52	$0.53	$350.23 million	$356.30 million	View	N/A
8/2/2012		$0.44	$0.53			View	N/A
5/8/2012		$0.60	$0.59			View	N/A
2/7/2012		$0.60	$0.58			View	N/A
11/2/2011		$0.57	$0.50			View	N/A
8/2/2011		$0.50	$0.46			View	N/A
5/9/2011		$0.62	$0.61			View	N/A
2/8/2011		$0.58	$0.57			View	N/A
11/3/2010	Q2 2011	$0.54	$0.55			View	N/A
8/3/2010	Q1 2011	$0.45	$0.46			View	N/A
5/6/2010	Q4 2010	$0.53	$0.55			View	N/A
2/2/2010	Q3 2010	$0.47	$0.69			View	N/A
11/3/2009	Q2 2010	$0.43	$0.54			View	N/A
7/30/2009	Q1 2010	$0.41	$0.43			View	N/A
5/7/2009	Q4 2009	$0.38	$0.49			View	N/A
1/27/2009	Q3 2009	$0.37	$0.53			View	N/A
10/30/2008	Q2 2009	$0.34	$0.48			View	N/A
7/30/2008	Q1 2009	$0.27	$0.43			View	N/A
5/7/2008	Q4 2008	$0.50	$0.59			View	N/A
1/30/2008	Q3 2008	$0.38	$0.35			View	N/A

(Earnings results data provided by Zacks Investment Research)

STERIS (NYSE:STE) Dividend Information

STERIS pays an annual dividend of $1.24 per share, with a dividend yield of 1.20%. STE's next quarterly dividend payment will be made on Thursday, June 28. The company has grown its dividend for the last 8 consecutive years and is increasing its dividend by an average of 10.30% each year. STERIS pays out 29.88% of its earnings out as a dividend.

Next Dividend:	6/28/2018
Annual Dividend:	$1.24
Dividend Yield:	1.20%
Dividend Growth:	10.30% (3 Year Average)
Payout Ratio(s):	29.88% (Trailing 12 Months of Earnings) 26.33% (Based on This Year's Estimates) 24.03% (Based on Next Year's Estimates) 23.21% (Based on Cash Flow)
Track Record:	8 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/11/2018	quarterly	$0.31	1.2%	6/7/2018	6/8/2018	6/28/2018
2/7/2018	quarterly	$0.31	1.35%	2/27/2018	2/28/2018	3/28/2018
11/1/2017	Quarterly	$0.31	1.42%	11/21/2017	11/22/2017	12/20/2017
8/8/2017	Quarterly	$0.31	1.46%	8/25/2017	8/29/2017	9/28/2017
5/9/2017	Quarterly	$0.28		6/5/2017	6/7/2017	6/29/2017
2/7/2017	Quarterly	$0.28	1.67%	2/24/2017	2/28/2017	3/28/2017
11/2/2016	Quarterly	$0.28	1.69%	11/21/2016	11/23/2016	12/21/2016
8/9/2016	Quarterly	$0.28	1.6%	8/26/2016	8/30/2016	9/27/2016
5/18/2016	quarterly	$0.25	1.43%	6/6/2016	6/8/2016	6/29/2016
2/9/2016	Quarterly	$0.25		2/26/2016	3/1/2016	3/29/2016
10/19/2015	quarterly	$0.25	1.45%	10/28/2015	10/30/2015	12/18/2015
8/5/2015	quarterly	$0.25	1.45%	8/21/2015	8/25/2015	9/22/2015
5/7/2015	quarterly	$0.23	1.35%	6/1/2015	6/3/2015	6/25/2015
2/5/2015	quarterly	$0.23	1.36%	2/23/2015	2/25/2015	3/25/2015
11/5/2014	quarterly	$0.23	1.47%	11/24/2014	11/26/2014	12/23/2014
8/6/2014	quarterly	$0.23	1.79%	8/22/2014	8/26/2014	9/23/2014
5/14/2014	quarterly	$0.21	1.58%	6/3/2014	6/5/2014	6/26/2014
2/6/2014	quarterly	$0.21	1.91%	2/24/2014	2/26/2014	3/26/2014
10/30/2013		$0.21		11/18/2013	11/20/2013	12/18/2013
8/7/2013	quarterly	$0.21	1.91%	8/26/2013	8/28/2013	9/25/2013
5/8/2013	quarterly	$0.19	1.69%	5/31/2013	6/4/2013	6/25/2013
2/7/2013	quarterly	$0.19	1.93%	2/25/2013	2/27/2013	3/27/2013

(Data available from 1/1/2013 forward)

STERIS (NYSE STE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 91.03%

Insider Trading History for STERIS (NYSE:STE)

Institutional Ownership by Quarter for STERIS (NYSE:STE)

STERIS (NYSE STE) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/18/2018	Michael B Wood	Director	Sell	3,800	$103.51	$393,338.00	22,331
5/15/2018	Sudhir K Pahwa	VP	Sell	2,000	$102.12	$204,240.00
5/11/2018	Karen L. Burton	VP	Sell	1,204	$102.74	$123,698.96
5/11/2018	Loyal W Wilson	Director	Sell	2,744	$103.29	$283,427.76	29,240
5/9/2018	Michael B Wood	Director	Sell	2,744	$100.00	$274,400.00
5/9/2018	Walter M Rosebrough Jr	CEO	Sell	10,000	$100.50	$1,005,000.00
4/23/2018	Sudhir K. Pahwa	VP	Sell	19	$97.00	$1,843.00
4/18/2018	Sudhir K. Pahwa	VP	Sell	1,981	$97.11	$192,374.91
3/12/2018	Walter M Rosebrough Jr	CEO	Sell	10,000	$95.50	$955,000.00
3/5/2018	Richard Martin Steeves	Director	Sell	58,953	$91.00	$5,364,723.00	9,362
2/28/2018	Jacqueline B Kosecoff	Director	Sell	2,744	$91.94	$252,283.36
2/26/2018	Cynthia L Feldmann	Director	Sell	3,218	$91.35	$293,964.30	11,214
2/13/2018	Karen L Burton	VP	Sell	1,500	$85.59	$128,385.00
1/29/2018	Sudhir K. Pahwa	VP	Sell	2,000	$92.09	$184,180.00
11/14/2017	John Adam Zangerle	VP	Sell	3,650	$88.00	$321,200.00
10/23/2017	Michael J Tokich	Insider	Sell	11,000	$92.00	$1,012,000.00	58,588
10/4/2017	Michael J Tokich	Insider	Sell	12,000	$89.75	$1,077,000.00
10/4/2017	Walter M Rosebrough Jr	CEO	Sell	10,000	$90.50	$905,000.00
9/8/2017	Richard Martin Steeves	Director	Sell	156,072	$87.13	$13,598,553.36	9,362
8/16/2017	Walter M Rosebrough Jr	CEO	Sell	10,000	$85.69	$856,900.00	83,270
8/15/2017	Karen L Burton	VP	Sell	3,270	$85.70	$280,239.00	11,807
8/9/2017	Mohsen Sohi	Director	Sell	2,744	$85.98	$235,929.12	21,816
7/3/2017	Michael B Wood	Director	Sell	4,000	$81.50	$326,000.00	26,131
6/16/2017	Kathleen Bardwell	Insider	Sell	3,795	$82.00	$311,190.00	20,605
6/13/2017	Daniel A. Carestio	Insider	Sell	4,745	$80.08	$379,979.60
6/2/2017	Walter M. Rosebrough, Jr.	CEO	Sell	10,000	$80.05	$800,500.00
6/1/2017	Kathleen Bardwell	Insider	Sell	4,000	$79.00	$316,000.00	20,975
6/1/2017	Sudhir K Pahwa	VP	Sell	3,000	$79.07	$237,210.00	22,047
5/25/2017	Sudhir K. Pahwa	VP	Sell	800	$77.28	$61,824.00
5/9/2017	Michael J Tokich	CFO	Sell	13,600	$76.00	$1,033,600.00	58,106
5/9/2017	Sudhir K. Pahwa	VP	Sell	200	$77.00	$15,400.00
5/3/2017	Daniel A Carestio	Insider	Sell	7,590	$75.17	$570,540.30	25,390
5/3/2017	John Adam Zangerle	VP	Sell	3,150	$75.00	$236,250.00	26,639
5/3/2017	Michael B Wood	Director	Sell	4,000	$75.00	$300,000.00	30,131
5/3/2017	Michael J Tokich	CFO	Sell	2,000	$75.00	$150,000.00	46,506
2/13/2017	Mohsen Sohi	Director	Sell	3,387	$67.66	$229,164.42	24,421
1/17/2017	Kathleen Bardwell	Insider	Sell	1,962	$68.78	$134,946.36	16,538
12/13/2016	John Adam Zangerle	VP	Sell	3,100	$69.00	$213,900.00	26,589
12/8/2016	Daniel A Carestio	Insider	Sell	2,225	$67.54	$150,276.50	20,025
11/15/2016	John Adam Zangerle	VP	Sell	2,200	$67.00	$147,400.00	26,166
11/4/2016	Cynthia L Feldmann	Director	Sell	4,744	$64.98	$308,265.12	14,581
9/7/2016	Richard Martin Steeves	Director	Sell	204,778	$71.19	$14,578,145.82	165,434
8/31/2016	Adrian Vincent Coward	Insider	Sell	15,000	$69.00	$1,035,000.00
8/26/2016	Sudhir K. Pahwa	VP	Sell	1,028	$70.13	$72,093.64
8/17/2016	Walter M. Rosebrough, Jr.	CEO	Sell	15,000	$71.08	$1,066,200.00
8/12/2016	Daniel A. Carestio	Insider	Sell	2,681	$71.04	$190,458.24
2/17/2016	Walter M. Rosebrough, Jr.	CEO	Sell	10,000	$64.27	$642,700.00
11/18/2015	Walter M Rosebrough Jr	CEO	Sell	11,960	$75.58	$903,936.80	111,376
11/9/2015	Kathleen Bardwell	insider	Sell	2,496	$73.85	$184,329.60	13,235
11/9/2015	Kevin M. Mcmullen	Director	Sell	8,000	$73.73	$589,840.00	26,338
11/3/2015	Mohsen Sohi	Director	Sell	3,000	$76.36	$229,080.00	20,250
10/30/2015	Daniel A. Carestio	insider	Sell	6,270	$74.00	$463,980.00	16,800
10/28/2015	Sudhir K Pahwa	VP	Sell	1,000	$70.09	$70,090.00	21,289
9/30/2015	Walter M Rosebrough Jr	CEO	Sell	5,000	$64.92	$324,600.00	116,376
9/29/2015	Walter M Rosebrough Jr	CEO	Sell	10,000	$64.43	$644,300.00	121,376
6/15/2015	David Allen Johnson	VP	Sell	1,826	$63.08	$115,184.08
6/10/2015	Walter M Rosebrough Jr	CEO	Sell	20,000	$63.80	$1,276,000.00
6/9/2015	Walter M Rosebrough Jr	CEO	Sell	5,000	$63.56	$317,800.00
8/11/2014	Michael B Wood	Director	Sell	5,300	$51.79	$274,487.00
6/2/2014	John Adam Zangerle	VP	Sell	2,000	$53.45	$106,900.00
5/12/2014	John Wareham	Director	Sell	15,000	$55.09	$826,350.00	23,256
4/2/2014	Michael Tokich	CFO	Sell	4,525	$51.68	$233,852.00	30,320
1/8/2014	Michael Tokich	CFO	Sell	4,200	$48.72	$204,624.00	30,320
11/26/2013	Cynthia Feldmann	Director	Sell	6,254	$45.97	$287,496.38	10,000
8/8/2013	Timothy Chapman	SVP	Sell	10,000	$43.84	$438,400.00	21,581
6/12/2013	Kevin M Mcmullen	Director	Sell	10,000	$44.09	$440,900.00
5/30/2013	Walter M Rosebrough Jr	CEO	Sell	2,000	$45.72	$91,440.00
5/22/2013	Mohsen Sohi	Director	Sell	10,000	$45.21	$452,100.00
5/21/2013	William L Aamoth	Treasurer	Sell	6,150	$45.96	$282,654.00
5/13/2013	David Allen Johnson	VP	Sell	2,680	$44.99	$120,573.20
10/5/2012	Michael J Tokich	CFO	Sell	4,100	$37.00	$151,700.00
8/9/2012	Cynthia L Feldmann	Director	Sell	23,122	$34.05	$787,304.10

(Data available from 1/1/2013 forward)

STERIS (NYSE STE) News Headlines

Source:

Date	Headline
	Head-To-Head Contrast: Intuitive Surgical (ISRG) & STERIS (STE) www.americanbankingnews.com - May 25 at 1:26 PM
	Medical Instruments Disinfections Market is Forecast to Cross US$ 5.0 Billion By 2024 www.marketwatch.com - May 24 at 4:47 PM
	Global Sterilization Equipment Market Growth Opportunities: Matachana Group, STERIS Corporation, Belimed AG www.marketwatch.com - May 24 at 9:07 AM
	Michael B. Wood Sells 3,800 Shares of STERIS (STE) Stock www.americanbankingnews.com - May 21 at 7:34 PM
	Zacks: Analysts Anticipate STERIS (STE) Will Post Quarterly Sales of $640.43 Million www.americanbankingnews.com - May 21 at 4:18 AM
	Zacks: Brokerages Anticipate STERIS (STE) to Post $0.98 Earnings Per Share www.americanbankingnews.com - May 19 at 9:25 AM
	Does STERIS plc’s (NYSE:STE) PE Ratio Signal A Buying Opportunity? finance.yahoo.com - May 18 at 4:54 PM
	Endoscope Reprocessing Market is Determined to Cross US$ 2.0 Billion By 2022 www.marketwatch.com - May 17 at 5:13 PM
	Infection Control Market is Determined to Cross US$ 18 Billion By 2024 www.marketwatch.com - May 17 at 5:13 PM
	STERIS (STE) VP Sells $204,240.00 in Stock www.americanbankingnews.com - May 16 at 8:16 PM
	Head-To-Head Analysis: Consort Medical (CSRMY) vs. STERIS (STE) www.americanbankingnews.com - May 16 at 1:29 PM
	STERIS (STE) Director Sells $283,427.76 in Stock www.americanbankingnews.com - May 14 at 7:59 PM
	STERIS (STE) VP Sells $123,698.96 in Stock www.americanbankingnews.com - May 14 at 7:58 PM
	STERIS plc www.streetinsider.com - May 13 at 9:33 AM
	STERIS (STE) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - May 11 at 8:29 PM
	STERIS (STE) Declares Quarterly Dividend of $0.31 www.americanbankingnews.com - May 11 at 5:45 PM
	STERIS (STE) Forecasted to Post Q1 2019 Earnings of $0.96 Per Share www.americanbankingnews.com - May 11 at 10:57 AM
	STERIS (STE) Director Sells $274,400.00 in Stock www.americanbankingnews.com - May 10 at 7:53 PM
	STERIS (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 Shares www.americanbankingnews.com - May 10 at 7:37 PM
	STERIS (STE) Q4 Earnings & Revenues Beat Estimates, Up Y/Y www.zacks.com - May 10 at 9:24 AM
	Edited Transcript of STE earnings conference call or presentation 9-May-18 2:00pm GMT finance.yahoo.com - May 10 at 9:24 AM
	STERIS (STE) Announces Quarterly Earnings Results www.americanbankingnews.com - May 9 at 5:55 PM
	STERIS Plc (STE) Q4 2018 Results - Earnings Call Transcript seekingalpha.com - May 9 at 4:45 PM
	STERIS (STE) Releases FY19 Earnings Guidance www.americanbankingnews.com - May 9 at 9:47 AM
	Steris: Fiscal 4Q Earnings Snapshot www.cnbc.com - May 9 at 9:15 AM
	Steris beats by $0.02, beats on revenue seekingalpha.com - May 9 at 9:15 AM
	STERIS Announces Financial Results for Fiscal 2018 Fourth Quarter and Full Year finance.yahoo.com - May 9 at 9:15 AM
	BRIEF-Steris Reports Q4 Earnings Per Share Of $0.86 www.reuters.com - May 9 at 9:15 AM
	STERIS Announces Changes to Board of Directors finance.yahoo.com - May 9 at 9:15 AM
	Factors of Influence in 2018, Key Indicators and Opportunity within Sonic ... globenewswire.com - May 3 at 4:38 PM
	STERIS (STE) and William Demant (WILYY) Financial Contrast www.americanbankingnews.com - May 3 at 11:17 AM
	STERIS (STE) Expected to Announce Quarterly Sales of $709.63 Million www.americanbankingnews.com - May 3 at 2:30 AM
	STERIS (STE) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - May 2 at 1:42 AM
	STERIS (STE) Scheduled to Post Earnings on Wednesday www.americanbankingnews.com - May 2 at 1:26 AM
	$1.22 Earnings Per Share Expected for STERIS (STE) This Quarter www.americanbankingnews.com - May 1 at 7:14 PM
	STERIS (STE) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - May 1 at 12:26 PM
	STERIS to Announce Fiscal 2018 Fourth Quarter and Full Year Financial Results on May 9, 2018 finance.yahoo.com - April 25 at 4:49 PM
	Varex Imaging Names Rosebrough To Board Of Directors finance.yahoo.com - April 23 at 8:56 AM
	STERIS (STE) VP Sudhir K. Pahwa Sells 1,981 Shares www.americanbankingnews.com - April 19 at 7:35 PM
	STERIS (STE) Expected to Post Quarterly Sales of $709.63 Million www.americanbankingnews.com - April 16 at 2:17 AM
	BidaskClub Downgrades STERIS (STE) to Buy www.americanbankingnews.com - April 14 at 9:13 PM
	$1.22 EPS Expected for STERIS (STE) This Quarter www.americanbankingnews.com - April 14 at 7:18 PM
	Medical Instrument Stocks Head-to-Head: Abiomed vs. STERIS finance.yahoo.com - April 13 at 9:29 AM
	STERIS (STE) Downgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 12 at 11:12 AM
	Steris PLC (STE) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - April 7 at 1:29 AM
	KeyCorp Reaffirms "Buy" Rating for Steris (STE) www.americanbankingnews.com - April 6 at 9:16 PM
	Steris (STE) Rating Reiterated by KeyCorp www.americanbankingnews.com - April 2 at 8:20 AM
	Steris PLC (STE) Expected to Announce Quarterly Sales of $709.63 Million www.americanbankingnews.com - March 30 at 1:50 AM
	$1.22 EPS Expected for Steris PLC (STE) This Quarter www.americanbankingnews.com - March 28 at 11:12 PM
	Steris (STE) Downgraded by Zacks Investment Research to "Hold" www.americanbankingnews.com - March 28 at 2:41 PM

STERIS (NYSE:STE) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

STERIS (NYSE:STE) Income Statement, Balance Sheet and Cash Flow Statement

STERIS (NYSE STE) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff